![Alexey Wolfson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alexey Wolfson active positions
Companies | Position | Start | End |
---|---|---|---|
MirImmune, Inc.
![]() MirImmune, Inc. BiotechnologyHealth Technology MirImmune, Inc. is a biopharmaceutical company that develops new generation immunotherapies for cancer. It combines two approaches to cancer treatment: immune checkpoint inhibition and cell-based immunotherapies. The company was founded by Alexey V. Eliseev, Alexey Wolfson, and Timothy Joseph Barberich on May 18, 2015 and is headquartered in Boston, MA. | Director/Board Member | - | - |
Founder | 2015-05-17 | - | |
Corporate Secretary | - | - | |
Chief Tech/Sci/R&D Officer | 2015-05-17 | - | |
Advirna LLC
![]() Advirna LLC BiotechnologyHealth Technology Advirna LLC engages in the development of new nucleic-based technologies for therapeutic and research use. It offers validated self-deliverable ribonucleic acid (SDRNA), in vivo SDRNA, transfection controls, starter kits, and custom SDRNA. The company was founded by Anastasia Khvorova and Alexey Wolfson in 2007 and is headquartered in Worcester, MA. | Chief Executive Officer | 2006-12-31 | - |
Founder | 2006-12-31 | - |
Career history of Alexey Wolfson
Statistics
International
United States | 3 |
Operational
Founder | 2 |
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoral
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
MirImmune, Inc.
![]() MirImmune, Inc. BiotechnologyHealth Technology MirImmune, Inc. is a biopharmaceutical company that develops new generation immunotherapies for cancer. It combines two approaches to cancer treatment: immune checkpoint inhibition and cell-based immunotherapies. The company was founded by Alexey V. Eliseev, Alexey Wolfson, and Timothy Joseph Barberich on May 18, 2015 and is headquartered in Boston, MA. | Health Technology |
Advirna LLC
![]() Advirna LLC BiotechnologyHealth Technology Advirna LLC engages in the development of new nucleic-based technologies for therapeutic and research use. It offers validated self-deliverable ribonucleic acid (SDRNA), in vivo SDRNA, transfection controls, starter kits, and custom SDRNA. The company was founded by Anastasia Khvorova and Alexey Wolfson in 2007 and is headquartered in Worcester, MA. | Health Technology |
- Stock Market
- Insiders
- Alexey Wolfson
- Experience